Acetylcholinesterase inhibitors for schizophrenia.

ABSTRACT:

Background

Antipsychotic medication remains the mainstay of treatment for schizophrenia and has been in use for a long time. As evidenced by ongoing research and partial effectiveness of the antipsychotics on cognitive and negative symptoms, the search is on for drugs that may improve these domains of functioning for someone suffering from schizophrenia. Acetylcholinesterase inhibitors have long been in use for treating cognitive symptoms of dementia.

Objectives

The aim of the review was to evaluate the clinical effects, safety and cost effectiveness of acetylcholinesterase inhibitors for treating people with schizophrenia

Search methods

We searched the Cochrane Schizophrenia Group's Register (February 2009), and inspected the references of all identified studies for

SUBMITTER: Singh J 

PROVIDER: S-EPMC6823258 | biostudies-literature | 2012 Jan

REPOSITORIES: biostudies-literature